动脉自旋标记MRI无创监测急性肺栓塞治疗反应
这项前瞻性研究纳入疑似肺栓塞参与者,用1.5T心电图触发伪连续动脉自旋标记MRI行肺灌注成像,对确诊肺栓塞者在治疗中位174天后复查。治疗后所有参与者肺灌注平均增加52%(P < .001),残余灌注缺损与持续呼吸困难显著相关(P = .008)。
要点
- ASL MRI可无创显示肺栓塞治疗前后肺灌注变化,所有参与者治疗后灌注平均增加52%。
- 随访时8例参与者仍有残余灌注缺损,共25个肺叶,与持续呼吸困难显著相关(P = .008)。
- 灌注缺损按五级评分(I级0%、II级≤25%、III级26%-50%、IV级51%-75%、V级>75%)逐肺叶评估。
核心结论
- ASL MRI可检测肺栓塞参与者抗血栓治疗后的肺灌注变化。
研究设计与样本
- 前瞻性研究,2020年11月至2022年12月纳入107例疑似肺栓塞参与者,其中15例确诊者治疗后复查。
- 使用1.5T心电图触发伪连续动脉自旋标记MRI,采用平衡稳态自由进动序列采集图像。
- 确诊肺栓塞者治疗后中位174天复查ASL MRI,另设15例无肺栓塞匹配队列和10名健康志愿者。
- 肺实质用高斯混合模型分割,灌注通过直方图分析量化。
关键影像表现/征象
- 所有纳入的肺栓塞参与者均可见灌注缺损,共累及59个肺叶:II级5个、III级10个、IV级17个、V级27个。
- 随访时8例参与者存在残余灌注缺损,共25个肺叶:II级7个、III级8个、IV级6个、V级4个(P = .002)。
诊断标准与关键数值
- 灌注缺损按肺叶五级评分:I级0%;II级25%或以下;III级26%-50%;IV级51%-75%;V级超过75%。
- 治疗后所有参与者肺灌注显著改善,平均增加52%(P < .001)。
- 治疗后灌注值与无肺栓塞参与者或健康对照相比无差异证据。
- 残余灌注缺损的存在与持续呼吸困难显著相关(P = .008)。
临床应用与阅片要点
- ASL MRI可作为无创肺灌注成像手段,用于肺栓塞抗血栓治疗后的灌注随访评估。
- 阅片时按肺叶五级评分记录灌注缺损,并关注随访时残余缺损与持续呼吸困难的关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To evaluate perfusion imaging with arterial spin labeling (ASL) MRI for monitoring the effects of antithrombotic therapy in participants with pulmonary embolism (PE). Materials and Methods Between November 2020 and December 2022, participants with suspected PE were enrolled in this prospective study and underwent lung perfusion imaging using electrocardiographically triggered pseudocontinuous ASL MRI with balanced steady-state free precession image acquisition at 1.5 T. Of these, participants with confirmed PE underwent follow-up ASL MRI after a median of 174 days after treatment. In participants with PE, perfusion defects were assessed lobe-wise using a five-point scale: grade I, 0%; grade II, 25% or less; grade III, 26%-50%; grade IV, 51%-75%; and grade V, more than 75%. Lung parenchyma was segmented using a Gaussian mixture model, and perfusion was quantified through histogram analysis. Association between clinical parameters and MRI results was also assessed. Results A total of 107 participants were enrolled; 15 participants (median age, 55 years [IQR, 39.5-72.5 years]; eight female) with confirmed PE underwent follow-up ASL MRI. A matched cohort of 15 participants without PE and 10 healthy volunteers also underwent ASL MRI. Perfusion defects were observed in all included participants with PE, affecting 59 lobes: grade II, five lobes; grade III, 10 lobes; grade IV, 17 lobes, and grade V, 27 lobes. On follow-up, defects persisted in eight participants, involving 25 lobes: grade II, seven lobes; grade III, eight lobes; grade IV, six lobes, and grade V, four lobes (P = .002). Lung perfusion significantly improved after treatment in all participants (mean increase, 52%; P < .001). There was no evidence of a difference in perfusion values after treatment from those of participants without PE or healthy controls. The presence of residual perfusion defects was significantly associated with persistent dyspnea (P = .008). Conclusion ASL MRI could detect changes in lung perfusion after antithrombotic therapy in participants with PE. Keywords: MR Perfusion, MRI, Thrombolysis, Pulmonary, Lung, Embolism, Thrombosis German Clinical Trials Register (DRKS00023599) Supplemental material is available for this article. © RSNA, 2025.
引用
- Liang C, Munz M, Martirosian P, et al. Arterial Spin Labeling MRI for Noninvasive Monitoring of Treatment Response in Acute Pulmonary Embolism. Radiol Cardiothorac Imaging. 2025. PMID: 41263664. doi:10.1148/ryct.240427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。